Jingjing He

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Helicobacter Pylori Infection

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Qi Zhang, Guang Li, Wen Zhao, Xifan Wang, Jingjing He, Limian Zhou, Xiaoxu Zhang, Peng An, Yinghua Liu, Chengying Zhang, Yong Zhang, Simin Liu, Liang Zhao, Rong Liu, Yixuan Li, Wenjian Jiang, Xiaoyu Wang, Qing-Yu Wang, Bing Fang, Yuyang Zhao, Yimei Ren, Xiaokang Niu, Dongjie Li, Shaoqi Shi, Wei-Lian Hung, Ran Wang, Xinjuan Liu, Fazheng Ren
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial. Nature communications 15 (1) (2024)
Teng Xu, Xu Zhang, Wenting Zhao, Jiaxin Shi, Sitong Wan, Yan Zhang, Yanling Hao, Mingyue Sun, Jingjing He, Li Jiang, Hao Wang, Hong Gao, Junjie Luo, Yongting Luo, Peng An
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis. Blood (2024)
Qi Zhang, Guang Li, Wen Zhao, Xifan Wang, Jingjing He, Limian Zhou, Xiaoxu Zhang, Peng An, Yinghua Liu, Chengying Zhang, Yong Zhang, Simin Liu, Liang Zhao, Rong Liu, Yixuan Li, Wenjian Jiang, Xiaoyu Wang, Qing-Yu Wang, Bing Fang, Yuyang Zhao, Yimei Ren, Xiaokang Niu, Dongjie Li, Shaoqi Shi, Wei-Lian Hung, Ran Wang, Xinjuan Liu, Fazheng Ren
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial. Nature communications 15 (1) (2024)
Qi Zhang, Guang Li, Wen Zhao, Xifan Wang, Jingjing He, Limian Zhou, Xiaoxu Zhang, Peng An, Yinghua Liu, Chengying Zhang, Yong Zhang, Simin Liu, Liang Zhao, Rong Liu, Yixuan Li, Wenjian Jiang, Xiaoyu Wang, Qing-Yu Wang, Bing Fang, Yuyang Zhao, Yimei Ren, Xiaokang Niu, Dongjie Li, Shaoqi Shi, Wei-Lian Hung, Ran Wang, Xinjuan Liu, Fazheng Ren
Efficacy of Bifidobacterium animalis subsp. lactis BL-99 in the treatment of functional dyspepsia: a randomized placebo-controlled clinical trial. Nature communications 15 (1) (2024)